Abstract:Stroke is one of most common causes of death and disability. Most of neuroprotective agents fail to rescue neurons from cerebral ischemic insults, mainly because of targeting downstream cascading events, such as excitotoxicity, oxidative and nitrosative stress, and inflammation, rather than improving hypoxia that initially occurs. Here, we report a near-infrared light (NIR)-driven nanophotosynthesis biosystem capable of generating oxygen and absorbing carbon dioxide, thus rescuing neurons from ischemia toward treating stroke. Through cerebral delivery of S. elongatus that spontaneously photosynthesize and upconversion nanoparticles (UCNPs), NIR with excellent tissue penetrating capability is converted to visible light by UCNPs to activate S. elongatus generating oxygen in vivo, enhancing angiogenesis, reducing infarction, and facilitating repair of brain tissues, thus improving neuronal function recovery. The combination of cell-biological, biochemical, and animal-level behavioral data provides compelling evidence demonstrating that this oxygen-generating biosystem through jointly utilizing microorganism and nanotechnology represents a novel approach to stroke treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.1c00719?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.1c00719</a>.Movie S1, 3D reconstruction images showing the colocalization of S. elongatus and microglia (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.1c00719/suppl_file/nl1c00719_si_001.mp4">MP4</a>)Details of materials and methods; purity identification of S. elongatus (Figure S1); microcystins testing (Figure S2); cyto-compatibility of S. elongatus on N2a and SHSY-5Y cells (Figures S3 and S4); weight changes and blood cell counts of mice that received S. elongatus injection (Figures S5 and S6); in vitro hemolysis assay (Figure S7); cyto-compatibility of UCNPs alone and the combination of UCNPs and S. elongatus (Figures S8 and S9); optimization of the power density of NIR (Figure S10); HP1, FJC, and TUNEL staining assays for NPT-treated MCAo mice (Figures S11–S13); weight changes of NPT-treated MCAo mice (Figure S14); mRNA levels of VEGF in S. elongatus-treated BV-2 cells (Figure S15); immunohistochemical staining of CD31 for NPT-treated MCAo mice (Figure S16); fluorescent signals and MRI images of brains received S. elongatus injection (Figures S17 and S18); biocompatibility of NPT on liver and kidney (Figure S19); in vivo neuro-compatibility of NIR (Figure S20) (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.1c00719/suppl_file/nl1c00719_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Mitochondria-Inspired Nanoparticles with Microenvironment-Adapting Capacities for On-Demand Drug Delivery after Ischemic Injury

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

A Novel Ultrasound‐Responsive Biomimetic Nanoparticle for Targeted Delivery and Controlled Release of Nitric Oxide to Attenuate Myocardial Ischemia Reperfusion Injury

Cobweb‐Inspired Microenvironment‐Targeting Nanosystem with Sequential Multiple‐Stage Stimulus‐Response Capacity for Ischaemic Tissue Repair

Mitochondrial-targeted and ROS-responsive nanocarrier <i>via</i> nose-to-brain pathway for ischemic stroke treatment

Mitochondria-targeted Antioxidant Delivery for Precise Treatment of Myocardial Ischemia–reperfusion Injury Through a Multistage Continuous Targeted Strategy

Rebuilding Postinfarcted Cardiac Functions by Injecting TIIA@PDA Nanoparticle-Cross-linked ROS-Sensitive Hydrogels

Platelet Membrane‐Encapsulated Nanocomplexes Based on Profundity Scavenging Ros Strategy for Myocardial Infarction Therapy

Oxygen-Generating Cyanobacteria Powered by Upconversion-Nanoparticles-Converted Near-Infrared Light for Ischemic Stroke Treatment

Nature-inspired Allomelanin Nanomedicine Alleviates Cardiac Ischemia/reperfusion Injury Via Scavenging Free Radicals and Ameliorating Myocardial Microenvironment

Supramolecular self‐assembled nanoparticles for targeted therapy of myocardial infarction by enhancing cardiomyocyte mitophagy

Salvaging myocardial infarction with nanoenzyme-loaded hydrogels: Targeted scavenging of mitochondrial reactive oxygen species

Biomimetic Design of Artificial Hybrid Nanocells for Boosted Vascular Regeneration in Ischemic Tissues

A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic Stroke

Preferential Targeting Cerebral Ischemic Lesions with Cancer Cell-Inspired Nanovehicle for Ischemic Stroke Treatment

An in Vivo Mirna Delivery System for Restoring Infarcted Myocardium.

An Injectable Hydrogel Containing Versatile Nanoparticles with Antioxidant and Antifibrotic Properties for Myocardial Infarction Treatment

Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia-Reperfusion Injury Through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue

Biodegradable Redox‐Responsive AIEgen‐Based‐Covalent Organic Framework Nanocarriers for Long‐Term Treatment of Myocardial Ischemia/Reperfusion Injury

Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective

Near-Infrared Light-Triggered Unfolding Microneedle Patch for Minimally Invasive Treatment of Myocardial Ischemia